Associate Professor, Medicine, Emory University School of Medicine
Infectious Disease
Dr. Vincent C. Marconi, MD
Vincent Marconi is an expert in the field of Infectious Disease. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. Dr. Vincent C. Marconi has written publications. He has 44 publications published with PubMed. The lastest publication is: 'Novel Predictors of Poor Retention Following a Down-referral from a Hospital-based ART Program in South Africa.' Vincent Marconi accepts Medicare.
Publications
- The Role of Behavioral Health in Optimizing Care for Complex Patients in the Primary Care Setting.
- Novel Predictors of Poor Retention Following a Down-referral from a Hospital-based ART Program in South Africa.
- Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia.
- Concurrent use of traditional medicine and ART: Perspectives of patients, providers and traditional healers in Durban, South Africa.
- Palliative HIV Care: Opportunities for Biomedical and Behavioral Change.
- Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz...
- Integrating Early Palliative Care for Patients With HIV: Provider and Patient Perceptions of Symptoms and Need for Services.
- Gender-Specific Risk Factors for Virologic Failure in KwaZulu-Natal: Automobile Ownership and Financial Insecurity.
- Antiretroviral reduction: is it time to rethink the unthinkable?
- Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations.
- The Continuum of HIV Care in a Veterans' Affairs Clinic.
- Early warning indicators for first-line virologic failure independent of adherence measures in a South african urban clinic.
- Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for c...
- Updates of Lifetime Costs of Care and Quality of Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry into Care.
- Early Post-Seroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1-Postive Subjects Receiving Antiretroviral Therapy.
- Commentary: Malaria and HIV transmission: old meets new in a deadly partnership or an opportunity for healthcare synergism?
- Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
- Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience.
- CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
- The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults.
- Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load.
- Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007.
- The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.
- Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced...
- Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007.
- Occupational exposure to blood and other bodily fluids at a military hospital in Iraq.
- Hospital-acquired device-associated infections at a deployed military hospital in Iraq.
- In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine.
- Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
- Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART.
- Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.
- Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.
- Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.
- Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.
- CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
- CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.
- HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
- Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.
- Neurocysticercosis.
- Coccidioidal meningitis after liver transplantation in a nonendemic region: a case report.
- The Combination of Pill Count and Self-Reported Adherence is a Strong Predictor of First-Line ART Failure for Adults in South Africa.
- Combining Epidemiologic and Biostatistical Tools to Enhance Variable Selection in HIV Cohort Analyses.
- A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS).
Schools
Johns Hopkins University School of Medicine
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Direct Access w/HSA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Emblem Health
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Education
-
Massachusetts General Hospital -
Brigham and Women's Hospital -
Johns Hopkins University School of Medicine
Hospital
-
Grady Memorial Hospital -
Emory University Hospital
Drug Facts
| NPI NUMBER | 1275511594 | |
| NPPES Provider LastName | MARCONI | |
| NPPES Provider FirstName | VINCENT | |
| NPPES Provider ZIPCode | 782365300 | |
| NPPES Provider State | TX | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 2956.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 66.0 | |
| Percent Opioid Claims | 2.23 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275511594 |
| Last Name Of The Provider | MARCONI |
| First Name Of The Provider | VINCENT |
| View All |
Similar Doctors
|
Dr. Dennis M. Melton, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Harold G. Stringer Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John E. McGowan Jr., MD |
|
|
Dr. George S. Kleris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos A. Diazgranados, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen F. Dunne, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Scott S. Santibanez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Spira, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|